| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8442548 | European Journal of Cancer | 2015 | 7 Pages |
Abstract
Combination of trastuzumab and XELOX is well tolerated and highly effective in patients with HER2-positive AGC.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Min-Hee Ryu, Changhoon Yoo, Jong Gwang Kim, Baek-Yeol Ryoo, Young Soo Park, Sook Ryun Park, Hye-Suk Han, Ik Joo Chung, Eun-Kee Song, Kyung Hee Lee, Seok Yun Kang, Yoon-Koo Kang,